jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

July. 14, 2023

April. 30, 2024

jRCTs031230230

Age related cerebral perfusion difference and safty in normal adult study by 123 I-IMP SPECT. .

Normal adult cerebral perfusion neuroimage study

Hirano Shigeki

Chiba University Hospital

1-8-1, Inohana, Chuo-ku, Chiba-City, Chiba, Japan

+81-43-222-7171

s_hirano@chiba-u.jp

Hirano Shigeki

Chiba University Hospital

1-8-1, Inohana, Chuo-ku, Chiba-City, Chiba, Japan

+81-43-226-2126

s_hirano@chiba-u.jp

Recruiting

July. 14, 2023

40

Interventional

single arm study

open(masking not used)

active control

single assignment

other

Those who meet all the following conditions are eligible.
1) Age at consent between 20 to 85.
2) Person who are capable of conducting studies within required period.
3) Subjects who have no problem if neuropsychological examination is performed within 3 months before obtaining informed consent
4) Subjects who are age-appropriate and have no problems if a head MRI scan has been performed within 3 months before obtaining informed consent
5) Subjects who have no problem in neuropsychological examination in the screening test after obtaining informed consent
6)Subjects who have age-appropriate brain MRI images and no problems in the screening test after obtaining informed consent
7)Person who are capable of providing written consent

Those who meet any of the following conditions are not eligible.
1) Those who are pregnant, or possible pregnancy, or breastfeeding.
2) Those with prior neurological or psychiatric disorders which could interfere with cognitive function.
3) Those with severe physical problem (e.g. in liver, kidney, or endocrine system).
4) Those having prior serious head trauma.
5) Those who are unable to perform MRI (i.e. metallic implants, claustrophobia, tatoos).
6) Those who have impared cognitive function.
7) Those who are incapable of completing the study, judged by the physician.

20age old over
85age old under

Both

Healthy adult

45 minutes continuous scan followed by 111MBq bolus injection of 123I-IMP.

History taking and neurological assessment in 40 healthy individuals and calculates average cerebral blood flow of whole brain.

1) Total MMSE score 24 or above are required.
2) ACEIII (Addenbrooke's Cognitive Examination Cognitive III) screening tests, consist of five cognitive domain (attention, memory, fuency, language, visuospatial). Total test time : 15 to 20 mins.
3) MoCA-J (Japanese version of Montreal Cognitive Cognitive Assessment) Screening testformild cognitive impairment. Total test time : 10 mins.
4) Japanese version of 4 A's test (4AT) is a screening test for delirium. Total test time 1 to 2 mins.
5) AQ-J (Japanese version of Autism spectrum Quotient) Assessment test for autism spectrum disorder. Total test time :10 mins.
6) BIS11(Barratt Impulsiveness Scale)Assessment test for impusiveness. Total test time : 10 mins.
7) BIS/BAS(Japanese version of ehavioral Inhibition System/Behavioral Activation System scale)Assessment tool for behavior inhibition system and behavior activation system. Total test time : 15 mins.
8) FAB(Frontal assessment battery)Screening test for frontal function. Total test time : 5 mins.
9) FOG-Q(Freezing of Gait questionnaire)Assessment test for gait freezing. Total test time:1 to 2 mins.
10) SED-11Q(Symptoms of Early Dementia 11 Questionnaire)Questionnaire for screening dementia and awareness of having dementia. Total test time:5 mins.
11) Forgiveness scale: Assessment tool for tendency to foregive. Total test time : 15 mins.
12) SF-MPQ(Short Form McGill Pain Questionnaire)Self rating scale for pain. Total test time : 5 mins
13) Noise pareidoria test: Screening and assessment tool for visual hallucination. Total test time : 5 mins.
14) Overactive Bladder Symptom Score: OABSS. Self reported questionnaire for urinary symptoms. Total test time:5 mins.
15) Parkinson's disease sleep scale 2:PDSS 2. Self reported questionnaire for sleping condition for the past 7 days. Total test time:5 mins
16) Evoked electroencephalogram (EEG).Simplifed EEG system built in a headphone, evoked by visual and auditory stimulation. P300 wave will be calculated and variability is assessed. Total test time :15 mins.

Clinical Research Initiation-Fund (of Chiba University Hospital)
Not applicable
Japan Agency for Medical Research and Development
Not applicable
Chiba University Certified Clinical Research Review Board
1-8-1, Inohana, Chuo-ku, Chiba-City, Chiba, Japan, Chiba

+81-43-226-2616

prc-jim@chiba-u.jp
Approval

none

History of Changes

No Publication date
2 April. 30, 2024 (this page) Changes
1 July. 14, 2023 Detail